Detalhe da pesquisa
1.
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
Lancet Oncol
; 21(2): 207-221, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31859245
2.
Combined inhibition of MDM2 and BCR-ABL1 tyrosine kinase targets chronic myeloid leukemia stem/progenitor cells in a murine model.
Haematologica
; 105(5): 1274-1284, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371419
3.
Biomarker Testing Journey Among Patients with Advanced Solid Tumors and Treatment Patterns by Homologous Recombination Repair Status: A Clinico-Genomic Database Study.
Adv Ther
; 41(2): 759-776, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38169059
4.
Association Between Homologous Recombination Repair Biomarkers and Survival in Patients With Solid Tumors.
JCO Precis Oncol
; 7: e2300195, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972338
5.
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.
Cancer Res
; 76(6): 1494-505, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719529